Small molecule Photoregulin3 prevents retinal degeneration in the RhoP23H mouse model of retinitis pigmentosa
Regulation of rod gene expression has emerged as a potential therapeutic strategy to treat retinal degenerative diseases like retinitis pigmentosa (RP). We previously reported on a small molecule modulator of the rod transcription factor Nr2e3, Photoregulin1 (PR1), that regulates the expression of p...
Main Authors: | Paul A Nakamura, Andy A Shimchuk, Shibing Tang, Zhizhi Wang, Kole DeGolier, Sheng Ding, Thomas A Reh |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2017-11-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/30577 |
Similar Items
-
Genetic dissection of non-syndromic retinitis pigmentosa
by: Aarti Bhardwaj, et al.
Published: (2022-01-01) -
A rat model for retinitis pigmentosa with rapid retinal degeneration enables drug evaluation in vivo
by: Chisato Inoue, et al.
Published: (2021-06-01) -
Role of spectral domain optical coherence tomography in assessment of macular morphological abnormalities in patients with retinitis pigmentosa
by: Walid Ibrahim, et al.
Published: (2017-01-01) -
Gene-agnostic approaches to treating inherited retinal degenerations
by: Lindsey A. Chew, et al.
Published: (2023-04-01) -
Novel codon 15 RHO gene mutation associated with retinitis pigmentosa
by: Vilela MAP, et al.
Published: (2018-11-01)